These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 23044428)

  • 1. Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cells.
    Moon SH; Ban K; Kim C; Kim SS; Byun J; Song MK; Park IH; Yu SP; Yoon YS
    Int J Cardiol; 2013 Sep; 168(1):41-52. PubMed ID: 23044428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome dynamics of human pluripotent stem cell-derived contracting cardiomyocytes using an embryoid body model with fetal bovine serum.
    Jung KB; Son YS; Lee H; Jung CR; Kim J; Son MY
    Mol Biosyst; 2017 Jul; 13(8):1565-1574. PubMed ID: 28671202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes.
    Yang X; Pabon L; Murry CE
    Circ Res; 2014 Jan; 114(3):511-23. PubMed ID: 24481842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.
    Ban K; Bae S; Yoon YS
    Theranostics; 2017; 7(7):2067-2077. PubMed ID: 28638487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Cultured Human Cardiomyocyte Clusters Obtained from Embryos/Fetuses or Derived from Human Embryonic Stem Cells.
    Grubb S; Vestergaard ML; Andersen AS; Rasmussen KK; Mamsen LS; Tuckute G; Grunnet-Lauridsen K; Møllgård K; Ernst E; Christensen ST; Calloe K; Andersen CY
    Stem Cells Dev; 2019 May; 28(9):608-619. PubMed ID: 30755084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pluripotent stem cell-based cardiac regenerative therapy for heart failure.
    Soma Y; Tani H; Morita-Umei Y; Kishino Y; Fukuda K; Tohyama S
    J Mol Cell Cardiol; 2024 Feb; 187():90-100. PubMed ID: 38331557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culture conditions affect cardiac differentiation potential of human pluripotent stem cells.
    Ojala M; Rajala K; Pekkanen-Mattila M; Miettinen M; Huhtala H; Aalto-Setälä K
    PLoS One; 2012; 7(10):e48659. PubMed ID: 23119085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo differentiation of induced pluripotent stem cell-derived cardiomyocytes.
    Yu T; Miyagawa S; Miki K; Saito A; Fukushima S; Higuchi T; Kawamura M; Kawamura T; Ito E; Kawaguchi N; Sawa Y; Matsuura N
    Circ J; 2013; 77(5):1297-306. PubMed ID: 23392122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forced aggregation and defined factors allow highly uniform-sized embryoid bodies and functional cardiomyocytes from human embryonic and induced pluripotent stem cells.
    Pesl M; Acimovic I; Pribyl J; Hezova R; Vilotic A; Fauconnier J; Vrbsky J; Kruzliak P; Skladal P; Kara T; Rotrekl V; Lacampagne A; Dvorak P; Meli AC
    Heart Vessels; 2014 Nov; 29(6):834-46. PubMed ID: 24258387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
    Ting S; Chen A; Reuveny S; Oh S
    Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Feaster TK; Cadar AG; Wang L; Williams CH; Chun YW; Hempel JE; Bloodworth N; Merryman WD; Lim CC; Wu JC; Knollmann BC; Hong CC
    Circ Res; 2015 Dec; 117(12):995-1000. PubMed ID: 26429802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin improved the generation of cardiomyocyte from human pluripotent stem cells for myocardial infarction repair.
    Zhang F; Qiu H; Dong X; Wang C; Na J; Zhou J; Wang C
    J Mol Histol; 2021 Feb; 52(1):87-99. PubMed ID: 33179120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrical Stimulation Enhances Cardiac Differentiation of Human Induced Pluripotent Stem Cells for Myocardial Infarction Therapy.
    Ma R; Liang J; Huang W; Guo L; Cai W; Wang L; Paul C; Yang HT; Kim HW; Wang Y
    Antioxid Redox Signal; 2018 Feb; 28(5):371-384. PubMed ID: 27903111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.
    Tan SH; Ye L
    J Cardiovasc Transl Res; 2018 Oct; 11(5):375-392. PubMed ID: 29557052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple, cost-effective but highly efficient system for deriving ventricular cardiomyocytes from human pluripotent stem cells.
    Weng Z; Kong CW; Ren L; Karakikes I; Geng L; He J; Chow MZ; Mok CF; Chan HYS; Webb SE; Keung W; Chow H; Miller AL; Leung AY; Hajjar RJ; Li RA; Chan CW
    Stem Cells Dev; 2014 Jul; 23(14):1704-16. PubMed ID: 24564569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
    van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
    Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice.
    Lou X; Tang Y; Ye L; Pretorius D; Fast VG; Kahn-Krell AM; Zhang J; Zhang J; Qiao A; Qin G; Kamp T; Thomson JA; Zhang J
    Cardiovasc Res; 2023 May; 119(4):1062-1076. PubMed ID: 36647784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction.
    Moon SH; Kang SW; Park SJ; Bae D; Kim SJ; Lee HA; Kim KS; Hong KS; Kim JS; Do JT; Byun KH; Chung HM
    Biomaterials; 2013 May; 34(16):4013-4026. PubMed ID: 23465823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.